Successful modification of a pp65 antigenemia-based early treatment strategy for prevention of cytomegalovirus disease in allogeneic marrow transplant recipients

Blood. 1999 Mar 1;93(5):1781-2.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Antigens, Viral / blood
  • Antiviral Agents / therapeutic use
  • Bone Marrow Transplantation / adverse effects*
  • Child
  • Child, Preschool
  • Cytomegalovirus Infections / blood
  • Cytomegalovirus Infections / diagnosis*
  • Cytomegalovirus Infections / prevention & control*
  • Humans
  • Infant
  • Middle Aged
  • Phosphoproteins / blood*
  • Time Factors
  • Transplantation, Homologous
  • Viral Matrix Proteins*

Substances

  • Antigens, Viral
  • Antiviral Agents
  • Phosphoproteins
  • Viral Matrix Proteins
  • cytomegalovirus matrix protein 65kDa